Proteomic profile of Aminoglutethimide (cas 125-84-8)-induced apoptosis in HL-60 cells: Role of myeloperoxidase and arylamine free radicals

Add time:09/27/2019    Source:sciencedirect.com

In this study, the cellular effects resulting from the metabolism of aminoglutethimide by myeloperoxidase were investigated. Human promyelocytic leukemia (HL-60) cells were treated with aminoglutethimide (AG), an arylamine drug that has a risk of adverse drug reactions, including drug-induced agranulocytosis. HL-60 cells contain abundant amounts of myeloperoxidase (MPO), a hemoprotein, which catalyzes one-electron oxidation of arylamines using H2O2 as a cofactor. Previous studies have shown that arylamine metabolism by MPO results in protein radical formation. The purpose of this study was to determine if pathways associated with a toxic response could be determined from conditions that produced protein radicals. Conditions for AG-induced protein radical formation (with minimal cytotoxicity) were optimized, and these conditions were used to carry out proteomic studies. We identified 43 proteins that were changed significantly upon AG treatment among which 18 were up-regulated and 25 were down-regulated. The quantitative proteomic data showed that AG peroxidative metabolism led to the down-regulation of critical anti-apoptotic proteins responsible for inhibiting the release of pro-apoptotic factors from the mitochondria as well as cytoskeletal proteins such as nuclear lamina. This overall pro-apoptotic response was confirmed with flow cytometry which demonstrated apoptosis to be the main mode of cell death, and this was attenuated by MPO inhibition. This response correlated with the intensity of AG-induced protein radical formation in HL-60 cells, which may play a role in cell death signaling mechanisms.

We also recommend Trading Suppliers and Manufacturers of Aminoglutethimide (cas 125-84-8). Pls Click Website Link as below: cas 125-84-8 suppliers

Prev:Aminoglutethimide (cas 125-84-8)-imprinted xerogels in bulk and spherical formats, based on a multifunctional organo-alkoxysilane precursor
Next:Recognitive nano-thin-film composite beads for the enantiomeric resolution of the metastatic breast cancer drug Aminoglutethimide (cas 125-84-8))